02
2022
-
06
Yuanzhikang, Gold Award! Lan Likang + Lan Jingkang, Gold Award!
On May 31, the winners of the 2022 China Swine Industry Anti-epidemic and Efficiency Technology Innovation Competition were announced. Sinopharm Animal Health's innovative projects Yuanzhikang, Lanlikang + Lanjingkang stood out and won the gold medal in the competition!
With the theme of "helping farmers to fight against the epidemic, improving quality and efficiency", this competition is guided by the National Pig Industry Technology Innovation Strategic Alliance, hosted by Jimu.com, undertaken by the New Pig School, Haid Group Research Institute, Wen's Group Research Institute, Kingkey Zhinong Research Institute and the Breeding Pig Quality Supervision, Inspection and Measurement Center of the Ministry of Agriculture and Rural Affairs (Guangzhou) are professional evaluation institutions, and are committed to discovering brands and products that have performed well in helping farmers fight against epidemics, improving quality and efficiency.
Yuanzhikang [porcine circovirus type 2, Mycoplasma hyopneumoniae dual inactivated vaccine (recombinant baculovirus CP08 strain + JM strain)] is independently developed by Sinopharm Animal Insurance, and is the first one-injection round-branched dual vaccine in China , The antigen content is high and accurate, and the antigen purity is high, which can ensure that the vaccine has strong immunogenicity and good protection. Yuanzhikang can prevent swine ring disease and Mycoplasma hyopneumoniae with one immunization. Compared with the traditional immunization program, the number of immunizations is reduced by 3 doses. It can also be combined with live blue ear vaccine and live swine fever vaccine for combined immunization. Reduce the number of immunizations and reduce immune stress, thereby improving the efficiency of pig farming.
Lan Likang [Porcine Reproductive and Respiratory Syndrome Chimeric Virus Live Vaccine (PC strain)] independently developed by Sinopharm Animal Health is the world's first and only genetically chimeric strain PRRS vaccine, and the only one that has obtained the Agricultural GMO Safety Certificate The vaccine has dual immune protection against classic and highly pathogenic PRRS, the strain does not detoxify, does not become strong, does not recombine, has excellent safety, and has high protection efficiency. It can be used for differential diagnosis and purification of PRRS. . Lanjingkang [Inactivated Porcine Reproductive and Respiratory Syndrome Vaccine (M-2 Strain)] uses domestic pig farms to isolate circulating strains, with strong immunogenicity, and can provide NADC30-like, NADC34-like and HP-PRRSV that are currently popular. Well protected. The immune combination of "Lanlikang + Lanjingkang" can provide a high level of protection efficiency and high safety at the same time. It can even purify PRRS and reduce the economic losses caused by PRRS to pig farms.
Yuanzhikang, one-shot immunity, simple and efficient! Lan Likang + Lan Jing Kang, Lan Lan combination, efficient blue control! After strict selection by the organizing committee, Sinopharm Animal Protection Yuanzhikang, Lanlikang + Lanjingkang were successfully shortlisted for the China Pig Industry Anti-epidemic and Efficiency Technology Innovation Competition, and won gold medals in many innovative projects.
RELATED INFORMATION
CONTACT US
ADDRESS: building A21, biological innovation park, No. 666, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei Province
Copyright © Sinopharm Animal Health Corporation Ltd. All Rights Reserved. SEO Powered by 300.cn